Details:
SK bioscience and the Doherty Institute will work to support and research in influenza biology, vaccines and antivirals. The program includes testing of anti-influenza compounds to identify new antivirals and development of quadrivalent cell culture-based influenza vaccine.
Lead Product(s): Quadrivalent Cell Culture-based Influenza Vaccine
Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed
Highest Development Status: Discovery Product Type: Vaccine
Partner/Sponsor/Collaborator: Doherty Institute
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration June 27, 2023
Details:
Celltrion achieved the first step of developing an antiviral treatment to fight COVID-19 and Plans to launch a fast self-testing diagnostic kit that could provide results within 15-20 minutes.
Lead Product(s): Monoclonal antibody
Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed
Highest Development Status: Discovery Product Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 23, 2020